British drugmaker Indivior's shares hit by copycat, new drug worries

Indivior shares fell more than 20 percent after the British drugmaker warned of a bigger-than-expected blow from a copycat of its top opioid addiction treatment and posted weak initial sales from its new blockbuster prospect.